Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 1/20 | 0.32 |
| ▸ | DRD1 | P21728 | 1/20 | 0.32 |
| ▸ | DRD5 | P21918 | 1/20 | 0.32 |
| ▸ | HRH1 | P35367 | 1/20 | 0.32 |
| ▸ | DRD3 | P35462 | 1/20 | 0.32 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.32 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.32 |
| ▸ | P4HB | P07237 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17037947 | 0.88 | DRD2 (0.33) | DRD2DRD1DRD5HRH1DRD3 | |
| SCHEMBL17037950 | 0.88 | DRD2 (0.32) | DRD2DRD1DRD5HRH1DRD3 | |
| SCHEMBL17037946 | 0.88 | DRD2 (0.31) | DRD2DRD1DRD5HRH1DRD3 | |
| SCHEMBL17037951 | 0.86 | DRD2 (0.31) | DRD2DRD1DRD5HRH1DRD3 | |
| SCHEMBL17037952 | 0.86 | DRD2 (0.31) | DRD2DRD1DRD5HRH1DRD3 | |
| SCHEMBL17037954 | 0.84 | DRD2 (0.31) | DRD2DRD1DRD5HRH1DRD3 | |
| SCHEMBL17037965 | 0.84 | DRD2 (0.31) | DRD2DRD1DRD5HRH1DRD3 | |
| SCHEMBL17037957 | 0.83 | DRD2 (0.31) | DRD2DRD1DRD5HRH1DRD3 | |
| SCHEMBL17037955 | 0.82 | DRD2 (0.31) | DRD2DRD1DRD5HRH1DRD3 | |
| SCHEMBL17037931 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9547009-B2 | Benzocyclooctyne compounds and uses thereof | ACADEMIA SINICA (TW) | 2017-01-17 | — | — | US | disclosed |
| US-20150241439-A1 | BENZOCYCLOOCTYNE COMPOUNDS AND USES THEREOF | ACADEMIA SINICA (TW) | 2015-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150241439-A1 | BENZOCYCLOOCTYNE COMPOUNDS AND USES THEREOF | AADAC, TBCA, SPG11 | DRD2 4423/4885DRD1 4568/4885DRD5 3651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.